Cerca
Psychoactive Substances
Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [11C]Raclopride
Objectives: Positron emission tomography (PET) with [11C]raclopride has been applied to measure changes in the concentration of endogenous dopamine induced by pharmacological challenge or neuropsychological stimulation by evaluating the...
Treating co-occurring substance use and mental health disorders using tools from CBT
Presented by Jo Cassar (The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney), by the end of this webinar, attendees will be able to:
- Recognise the importance of assessing for substance use when a...
Eating disorders and AOD use: what clinicians need to know
Presented by Associate Professor Sarah Maguire (Director, InsideOut Institute), by attending this webinar, attendees will learn:
- How to recognise the most common eating disorder symptoms;
- Eating disorder interventions and how workers...
Kenya to include smoking cessation drugs as essential medicines
The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction.
The World Health Organization said the two drugs bring “a powerful shift in the...
Multiple disadvantage and co-occurring substance use and mental health conditions.
Substance use and mental health needs are two of the primary concerns for many people experiencing multiple disadvantage. We know that people who experience both issues at the same time (also known as “co-occurring conditions” or “dual...
L'impatto della discriminazione sui disturbi da uso di sostanze tra le minoranze sessuali
Questo documento mirava a rivedere la letteratura riguardante l'impatto della discriminazione sui disturbi da uso di sostanze tra le minoranze sessuali, con particolare attenzione ad alcol, oppioidi, stimolanti, policonsumo di droghe...
L'Ecolink Institute inaugura la formazione UTC in hindi
L'Ecolink Institute avvia la formazione UTC in hindi
Mangalore: Dal 6 luglio 2022 l'Ecolink Institute of well-being, con sede a Mangalore, un fornitore di formazione approvato dal Piano Colombo, ha avviato una formazione speciale su...
Nuove sostanze psicoattive (NPS) - la situazione irlandese.
La presente scheda informativa riassume le informazioni e le statistiche sulle nuove sostanze psicoattive raccolte dalle recenti relazioni sulla prevalenza, il trattamento, la mortalità e la legislazione in Irlanda.
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
World Drug Report 2022
The 2022 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances (NPS), as well as their impact on health.
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract
Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain.
Objective To examine whether prenatal...
Another Milestone for Kenya: Launch of the National Standard on Management of Persons with Substance Use Disorders
According to the International Standards for the Treatment of Drug Use Disorders (2020), the use of psychoactive drugs or narcotic drugs and psychotropic substances without medical supervision is associated with significant health risks...
Accreditation of Study Programs on Addictions in Nigerian Universities: Challenges, Opportunities, and the Need for Advocacy
INTRODUCTION:
Access to drug treatment services in Nigeria remains low due to a severe shortage in the drug treatment workforce. Plans are underway to address the workforce shortage by introducing drug addiction training programs in...
AddictologyIssue 1/2022
Serie di webinar sulle nuove sostanze psicoattive (NPS)
Varie NPS hanno cambiato in modo significativo il quadro del consumo di droga in diversi paesi. Ora sono molto importanti nel mercato della droga. In effetti, molte di queste sostanze hanno lo scopo di aggirare le leggi sulle droghe e sono...
Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors
Abstract
Cocaine addiction is a significant medical and public concern. Despite decades of research effort, development of pharmacotherapy for cocaine use disorder remains largely unsuccessful. This may be partially due to insufficient...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
Comorbid mental illnesses and substance use disorders are associated with adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among prison populations. We therefore aimed to estimate the prevalence of comorbid serious mental illnesses and substance use disorders (dual disorders) among people in prison worldwide.
Nuove sostanze psicoattive (NPS): mercato nero e politica delle nuove sostanze psicoattive nella regione asiatica
ISSUP Kazakistan ha presentato il terzo webinar della serie sulle nuove sostanze psicoattive, con un focus sul mercato nero e sulla politica delle nuove sostanze psicoattive nella regione asiatica.
New Psychoactive Substances: Reading List
New psychoactive substances (NPS) are a diverse group of substances designed to replicate the effects of substances like cannabis, cocaine and ecstasy.
Moduli di formazione del progetto NEPTUNE
In collaborazione con il Royal College of Psychiatrists, project NEPTUNE ha sviluppato moduli di formazione per migliorare la pratica clinica nella gestione dei danni derivanti dall'uso di droghe club e nuove sostanze psicoattive.
Questi...
Guida alla gestione clinica dei danni acuti e cronici delle droghe club e delle nuove sostanze psicoattive
Questo documento fornisce indicazioni sulla gestione clinica dei danni derivanti dall'intossicazione acuta e dall'uso nocivo e dipendente di droghe club e nuove sostanze psicoattive (NPS).
Questo è un riferimento ampio e completo rivolto...